Strategic Blueprint’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
Other funds holding CELG
FP
HCM
PCMC
WCG
Strategic Blueprint's CELG Position: Q4 2019 in Review
Strategic Blueprint sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 635 shares — an estimated $63K sold.
Strategic Blueprint first reported a position in CELG in Q3 2019 and held it in 1 quarter. The position peaked at $63K in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Strategic Blueprint reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Strategic Blueprint sold 635 Celgene Corp shares in Q4 2019, an estimated $63K.
- Strategic Blueprint first reported a position in Celgene Corp in Q3 2019 and held it in 1 quarter.
- Strategic Blueprint's Celgene Corp position peaked at $63K in Q3 2019.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Strategic Blueprint's 13F filing for Q4 2019, filed 10 Jan 2020.